Estamos realizando la búsqueda. Por favor, espere...
Abstract: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly (EBV+ DLBCL-e) is a molecularly distinct variant of DLBCL, characterized by a monoclonal B-cell proliferation that occurs in patients >50 years of age without a history or clinicopathologic evidence of immunodeficiency. However, patients with EBV+ DLBCL younger than 50-years-old also exist in Western countries. We evaluated the clinicopathologic, immunophenotypic and genetic features in Cacausian patients with EBV+ DLBCL who are =50 years of age and compared this patient group to patients who are >50 years. In patients who are =50 years, less frequent expression of BCL6 and a trend of more frequent expression of CD30 and pSTAT3 were found in patients with EBV+ DLBCL. In patients who are >50 years, common expression of CD30, p50, pSTAT3 and less frequent expression of BCL6 were observed. Older patients also more commonly had a poor performance status (ECOG=2). Comparing EBV+ DLBCL patients in =50 years versus >50 years, both groups had similar clinicopathologic, immunophenotypic and genetic features. Gene expression profiling, microRNA profiling and treatment outcome of the younger patients with EBV+ DLBCL was not distinctive from tumors in older patients. Based on our data, we suggest that the arbitrary age cutoff for EBV+ DLBCL is unnecessary and should be eliminated in the WHO lymphoma classification scheme.
Fuente: Oncotarget. 2015 Jun 10; 6(16): 13933–13945.
Editorial: Impact Journals
Fecha de publicación: 10/06/2015
Nº de páginas: 13
Tipo de publicación: Artículo de Revista
Consultar en UCrea
OK, CHI YOUNG
MANYAM, GANIRAJU C.
GOSWAMI, RASHMI R.
SANTIAGO MONTES MORENO
SOHANI, ALIYAH R.
MIGUEL ANGEL PIRIS PINILLA
RICHARDS, KRISTY L.